New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 9, 2018 - 60 Degrees Pharmaceuticals announced the FDA approval of Arakoda (tafenoquine), for the prophylaxis of malaria in patients aged 18 years and older.
Download PDF
Return to publications
